Human F8 / Factor VIII Antibody (Novo Nordisk patent anti-Factor VIII, Research Use)

Product Name	Human F8 / Factor VIII Antibody (Novo Nordisk patent anti-Factor VIII, Research Use)
Catalog Number	NBR-0745
Alias/Synonyms	DXS1253E; FVIII; FVIII; F8C; AHF
Appearance	Transparent Liquid
Molecule Weight	150kDa
CAS	N/A
Solubility	Water, PBS, TBS Buffer,etc.
Storage	Temp. -80℃
Shelf Life	see COA
Additional info 1	CHO Expressed
Additional info 2	Ab. Isotype - IgG

Catalog Numbe	Size	Price	Inventory Level
NBR-0745-100UG	100ug	$95	Inquire
NBR-0745-1MG	1mg	$650	Inquire
NBR-0745-5MG	5mg	$1395	Inquire

【Introduction】

Product Name: Human F8 / Factor VIII Antibody (Novo Nordisk patent anti-Factor VIII, Research Use)
Catalog Number: NBR-0745
Target Name: F8 / Factor VIII
Trade Name: Novo Nordisk patent anti-Factor VIII
Antibody Drug Description: The drug is a recombinant fully human anti-Factor VIII monoclonal antibody, being developed by Novo Nordisk.

【Description】

Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

【Gene Information】

Gene Name: F8
Synonyms: DXS1253E; FVIII; FVIII; F8C; AHF
Target Description: Factor VIII, along with calcium and phospholipid, acts as a cofactor for F9/factor IXa when it converts F10/factor X to the activated form, factor Xa.
Ensembl: ENSG00000185010
Uniprot: P00451

Top-selling Items